| 000 | 00759 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513061441.0 | ||
| 264 | 0 | _c19931104 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0006-6648 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalant, L P | |
| 245 | 0 | 0 |
_aAdvantages and synergism of combined pharmacokinetic and pharmacodynamic studies during drug development. _h[electronic resource] |
| 260 |
_bBollettino chimico farmaceutico _cJun 1993 |
||
| 300 |
_a212-3 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacokinetics |
| 700 | 1 | _aBalant-Gorgia, A E | |
| 773 | 0 |
_tBollettino chimico farmaceutico _gvol. 132 _gno. 6 _gp. 212-3 |
|
| 999 |
_c8103748 _d8103748 |
||